Physician profile
Janis Fee
NPI 1891781175
$2,898.34
in general payments reported to CMS, 2019-2025
21 companies · $45.00 in 2025
The $45.00 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,370 · 2020: $358 · 2021: $212 · 2022: $373 · 2023: $160 · 2024: $381 · 2025: $45.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465 · Gift: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.98 |
| Gift | $120.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $605.05 | 2019-2025 | |
| Minerva Surgical, INC | $556.82 | 2019-2022 | |
| Abbvie INC. | $531.81 | 2019-2023 | |
| Therapeuticsmd, INC. | $235.59 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $111.75 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $110.00 | 2024 | Enhertu |
| Tesaro, INC. | $105.40 | 2019 | |
| Seagen INC. | $92.06 | 2022 | |
| Avion Pharmaceuticals | $75.04 | 2021-2022 | |
| Hologic Sales and Service, LLC | $73.07 | 2019-2025 | Acessa Provu System |
| Allergan, INC. | $68.67 | 2019 | |
| Daiichi Sankyo INC. | $50.62 | 2019 | |
| Vertical Pharmaceuticals, LLC | $45.94 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $41.92 | 2019 | |
| Amag Pharmaceuticals, INC. | $40.38 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $39.82 | 2019-2020 | |
| Duchesnay USA Incorporated | $30.23 | 2019 | |
| Mayne Pharma Commercial LLC | $28.43 | 2023 | |
| Glaxosmithkline, LLC. | $23.82 | 2024 | Jemperli, Zejula |
| Mylan Pharmaceuticals INC. | $17.53 | 2022 | |
| Coloplast Corp | $14.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janis Fee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.